NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00129558 2013-12-04A Study to Evaluate PT-523 in Patients With Refractory LeukemiaSpectrum Pharmaceuticals, IncPhase 1/2 Withdrawn
NCT00044733 2006-05-18Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell TransplantWyeth is now a wholly owned subsidiary of PfizerPhase 2 Completed38 enrolled